GRAYBUG
GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.
GRAYBUG
Social Links:
Industry:
Biotechnology Health Care Medical Wellness
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.graybug.vision
Total Employee:
51+
Status:
Active
Contact:
650-487-2800
Email Addresses:
[email protected]
Total Funding:
129.24 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Pound Sterling Japanese Yen WP Engine
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - GrayBug
Deerfield Capital Management
Deerfield Capital Management investment in Series C - GrayBug
C-Bridge Capital
C-Bridge Capital investment in Series C - GrayBug
Clarus Ventures
Clarus Ventures investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - GrayBug
OrbiMed
OrbiMed investment in Series B - GrayBug
Deerfield
Deerfield investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - GrayBug
Maryland Venture Fund
Maryland Venture Fund investment in Series A - GrayBug
Official Site Inspections
http://www.graybug.vision
- Host name: 172.67.156.185
- IP address: 172.67.156.185
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GrayBug"
Mission Statement, Vision, & Core Values (2025) of Graybug …
Company's Mission Statement The mission statement of Graybug Vision, Inc. (NASDAQ: GRAY) serves as a foundational guideline that influences its strategic direction and operational …See details»
Overview | Graybug Vision, Inc.
The Investor Relations website contains information about Graybug Vision, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
GrayBug - Crunchbase Company Profile & Funding
GrayBug is a pharmaceutical company that develops transformative medicines for ocular diseases. They also develop therapies for inflammatory diseases with …See details»
Graybug Vision - VentureRadar
Graybug Vision is a clinical stage pharmaceutical company developing novel products for the treatment of ocular diseases. The company's proprietary injectable products are designed to …See details»
Graybug Vision, Inc. - AnnualReports.com
Graybug is a biopharmaceutical company focused on developing transformative medicines for ocular diseases. Founded in 2011 based on technology licensed from the Johns Hopkins University School of Medicine, Graybug has offices in …See details»
Graybug Vision, Inc. (GRAY): history, ownership, mission, how it …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Graybug Vision, Inc. (GRAY) Company Formation and Initial Development Graybug Vision, …See details»
Graybug Vision 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Graybug Vision. Use the PitchBook Platform to explore the full profile.See details»
Graybug Vision, Inc. (GRAY): history, ownership, mission, how it …
Graybug Vision, Inc. (GRAY) is a biopharmaceutical company that is focused on developing transformative therapies to treat vision-threatening diseases. The ownership of Graybug …See details»
Graybug Vision (NAS: GRAY) - baltimore.tech
Graybug Vision (NAS: GRAY). We work relentlessly to save sight through transformative science, creating practical solutions to treat vision-threatening diseases, that improve quality of life and …See details»
Graybug to Present Clinical Development Plan ... - Graybug Vision, …
BALTIMORE, May 19, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for …See details»
GrayBug: Disruptive RX for Your Eyes - Inc.com
Jun 25, 2013 Warby Parker isn’t the only start-up disrupting the vision space. GrayBug, a company that recently won the Invest Maryland Challenge in Baltimore, Maryland, is revolutionizing drug delivery and ...See details»
All Eyes on Graybug Vision! Here’s Why! - Avise Analytics
Jun 14, 2021 Graybug Vision is a clinical-stage biopharmaceutical company seeking to find treatment solutions to combat combat vision—threatening diseases including macular …See details»
Graybug Vision, founded out of Johns Hopkins, expects to raise …
Sep 25, 2020 Graybug Vision, founded out of Johns Hopkins, expects to raise $90M in IPO Spun out of Hopkins' Wilmer Eye Institute, the biopharmaceutical company has an R&D center …See details»
Graybug Vision - VentureRadar
GrayBug USA Private Graybug Vision is a clinical stage pharmaceutical company developing novel products for the treatment of ocular diseases. The company's proprietary injectable …See details»
Graybug Vision Inc. - Cruelty Free Investing
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The …See details»
Graybug Vision - IPOScoop
Graybug Vision | IPOScoopGraybug Vision PrintSee details»
Vision Extrusions Group Limited - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vision Extrusions Group Limited of Woodbridge, ON. Get the latest business insights from Dun & …See details»
Home - PRISM Vision Group
Feb 25, 2025 PRISM Vision Group is a physician-lead administrative service organization (ASO) that partners eye care practices in the United States to provide improved patient care and …See details»
Vision Automation Limited Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vision Automation Limited of Woodbridge, ON. Get the latest business insights from Dun & Bradstreet.See details»
Department for the Blind and Vision Impaired - Virginia.gov
The Department for the Blind and Vision Impaired (DBVI) is committed to providing quality services to assist Virginia's citizens who are blind, deafblind or vision impaired in achieving …See details»